Pravastatin
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Pravastatin is a moderate-intensity hydrophilic statin with proven cardiovascular benefits in primary and secondary prevention. Unlike lipophilic statins, it is not metabolized by CYP3A4 or CYP2D6, resulting in fewer drug interactions.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Pravastatin is a moderate-intensity hydrophilic statin with proven cardiovascular benefits in primary and secondary prevention. NutriStack rates the supporting evidence as strong. Common adult dosing is 10–80 mg once daily (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete coq10. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: lowers ldl cholesterol by 22–37%, proven reduction in coronary events (woscops, care trials), favorable drug interaction profile. 10 sources indexed (2007–2024), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Active drug that directly inhibits HMG-CoA reductase without requiring metabolic activation. Its hydrophilic nature confers hepatic selectivity via active transport into hepatocytes by organic anion transporting polypeptide (OATP). Reduces LDL-C by decreasing cholesterol synthesis and upregulating LDL receptors.4
Dosing & protocol.
Can be taken with or without food; hydrophilic statin with minimal CYP450 interactions
What it depletes.
Nutrients this medication can lower over time, and what to replace.
CoQ10
ModerateHMG-CoA reductase inhibition reduces mevalonate pathway flux, lowering endogenous CoQ10 synthesis alongside cholesterol synthesis.
Full safety detail.
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1The role of pravastatin in preventing preeclampsia in high-risk pregnant women: a meta-analysis with trial sequential analysisPMIDProvinciatto H, Barbalho ME, Almeida J et al. · American journal of obstetrics & gynecology MFM · 2024
Provinciatto H, Barbalho ME, Almeida J et al.. The role of pravastatin in preventing preeclampsia in high-risk pregnant women: a meta-analysis with trial sequential analysis. American journal of obstetrics & gynecology MFM. 2024
- 2Pravastatin and placental insufficiency associated disorders: A systematic review and meta-analysisPMIDHirsch A, Rotem R, Ternovsky N et al. · Frontiers in pharmacology · 2022
Hirsch A, Rotem R, Ternovsky N et al.. Pravastatin and placental insufficiency associated disorders: A systematic review and meta-analysis. Frontiers in pharmacology. 2022
- 3Pravastatin in preeclampsia: A meta-analysis and systematic reviewPMIDMészáros B, Veres DS, Nagyistók L et al. · Frontiers in medicine · 2022
Mészáros B, Veres DS, Nagyistók L et al.. Pravastatin in preeclampsia: A meta-analysis and systematic review. Frontiers in medicine. 2022
- 4Effect of pravastatin treatment on circulating adiponectin: a meta-analysis of randomized controlled trialsPMIDShu X, Chi L · Drug design, development and therapy · 2019
Shu X, Chi L. Effect of pravastatin treatment on circulating adiponectin: a meta-analysis of randomized controlled trials. Drug design, development and therapy. 2019
- 5Does pravastatin promote cancer in elderly patients? A meta-analysisPMIDBonovas S, Sitaras NM · CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2007
Bonovas S, Sitaras NM. Does pravastatin promote cancer in elderly patients? A meta-analysis. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2007
Reference material
5- 6Shepherd J et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia (WOSCOPS). N Engl J Med. 1995.Source linkedPMID
- 7Sacks FM et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels (CARE). N Engl J Med. 1996.Source linkedPMID
- 8Li W et al. A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases. Cardiovasc Ther. 2025.Source linkedPMID
- 9Costantine MM, West H, Wisner KL et al.. A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia. American journal of obstetrics and gynecology. 2021Source linkedPMID
- 10Döbert M, Varouxaki AN, Mu AC et al.. Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia. Circulation. 2021Source linkedPMID
Common questions.
Quick answers about Pravastatin, drawn from the data on this page.
What is Pravastatin?
Pravastatin is a moderate-intensity hydrophilic statin with proven cardiovascular benefits in primary and secondary prevention. Unlike lipophilic statins, it is not metabolized by CYP3A4 or CYP2D6, resulting in fewer drug interactions.
What is Pravastatin used for?
Commonly cited benefits of Pravastatin include: Lowers LDL cholesterol by 22–37%; Proven reduction in coronary events (WOSCOPS, CARE trials); Favorable drug interaction profile; Well-tolerated in patients on multiple medications. NutriStack rates the overall evidence as strong.
What is a typical dose of Pravastatin?
A typical adult dose of Pravastatin is 10–80 mg once daily (as prescribed by your physician). The commonly recommended form is Oral tablet. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Pravastatin?
Reported side effects include myalgia, nausea and vomiting, headache, rash, diarrhea, elevated liver transaminases. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Pravastatin?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Pravastatin in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.